Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00718107|
Recruitment Status : Terminated (The study was discontinued due to low enrollment. A survey has been implemented in place of a formal study.)
First Posted : July 18, 2008
Last Update Posted : March 5, 2013
The purpose of this study is :
- To assess the ALS patient's satisfaction related to a hospital stay on the neurology floor of Hahnemann Hospital.
- To compare the reported satisfaction of those individuals who stayed in a standard hospital room with those who stayed in Room 1455. Room 1455 is a room specifically set up with assistive technology related to environmental controls for individuals with disabilities.
- To look at frequency of use of the various pieces of adaptive equipment.
|Condition or disease|
|Amyotrophic Lateral Sclerosis Neurodegenerative Disease Motor Neuron Disease|
|Study Type :||Observational|
|Actual Enrollment :||5 participants|
|Official Title:||Satisfaction Survey for ALS Patients Comparing Rooms With and Without Assistive Technology|
|Study Start Date :||June 2005|
|Actual Primary Completion Date :||February 2012|
|Actual Study Completion Date :||February 2012|
U.S. FDA Resources
Subjects having either definite or probable ALS by El Escorial Criteria.
- Patient Satisfaction [ Time Frame: Period of Hospital Stay ]Survey administered asks patients to rate their satisfaction with their hospital stay from Very Dissatisfied to Very Satisfied. Specific questions included satisfaction with hospital staff, quality of care, and comfort and accessibility of their room.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00718107
|United States, Pennsylvania|
|MDA/ALS Center of Hope|
|Philadelphia, Pennsylvania, United States, 19107|